STAT+: FDA approves Vera Therapeutics kidney disease treatment

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program

The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea

Study links dihydropyridine calcium channel blockers to worse kidney outcomes in type 2 diabetes patients

A study presented at the European Renal Association Congress found that dihydropyridine calcium channel blockers (DCCBs), a commonly prescri

Untitled

FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company

The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ

FDA reconsidering gene therapy for Huntington's disease after official who rejected it leaves agency

A gene therapy for Huntington's disease from UniQure has gained a new path toward FDA approval following the ouster of Trump administration

Life Biosciences Doses First Patient in FDA-Approved Gene Therapy Trial for Age-Related Blindness

Life Biosciences has dosed its first patient in an FDA-approved clinical trial testing a gene therapy designed to reverse cellular aging. Th